Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure [NA]

View source ↗

Summary

The clinical trial evaluating risk- and benefit-informed pharmacist MTM intervention for heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Geisinger Clinic | Conditions: Heart Failure | NA | Status: TERMINATED